MedTrace Logo

Echinacea and Acute Respiratory Illness

NCT02003651 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2016-12-13

No results posted yet for this study

Summary

The primary objective of this study is to evaluate the effectiveness of ingesting an alkylamide-rich echinacea root product (Quick Defense, Gaia Herbs) for 2 days immediately following each onset of acute respiratory illness (ARI) symptomatology during a 12-week period in the winter and early spring in women.

Hypothesis: Subjects randomized to Quick Defense compared to placebo over a 12-week period will experience reduced ARI symptomatology, both acutely during each ARI episode and collectively over the entire 12-week study period.

Conditions

  • Acute Respiratory Infections

Interventions

DIETARY_SUPPLEMENT

Quick Defense

Echinacea product from Gaia Herbs.

DIETARY_SUPPLEMENT

Placebo

Placebo

Sponsors & Collaborators

  • Gaia Herbs Inc.

    collaborator INDUSTRY

  • Appalachian State University

    lead OTHER

Principal Investigators

  • David C. Nieman, DrPH · Appalachian State University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2014-04-30
Completion
2014-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02003651 on ClinicalTrials.gov